Strain-resolved microbiome sequencing reveals mobile elements that drive bacterial competition on a clinical timescale.
Anti-Infective Agents
/ pharmacology
Azacitidine
/ pharmacology
Azithromycin
/ pharmacology
Bacteria
/ classification
Ciprofloxacin
/ pharmacology
DNA, Bacterial
Diet
Feces
/ microbiology
Gastrointestinal Microbiome
/ drug effects
Genome, Bacterial
Hematopoietic Stem Cell Transplantation
Humans
Immunosuppressive Agents
/ pharmacology
Male
Metagenome
Middle Aged
Myelodysplastic Syndromes
/ microbiology
Primary Myelofibrosis
/ microbiology
RNA-Seq
Sequence Analysis, DNA
Antibiotic resistance
DNA
Gut microbiome
Linked reads
Metagenomics
Read cloud assembly
Sequencing
Strain diversity
Structural variation
Journal
Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844
Informations de publication
Date de publication:
29 05 2020
29 05 2020
Historique:
received:
19
12
2019
accepted:
11
05
2020
entrez:
31
5
2020
pubmed:
31
5
2020
medline:
14
5
2021
Statut:
epublish
Résumé
Populations of closely related microbial strains can be simultaneously present in bacterial communities such as the human gut microbiome. We recently developed a de novo genome assembly approach that uses read cloud sequencing to provide more complete microbial genome drafts, enabling precise differentiation and tracking of strain-level dynamics across metagenomic samples. In this case study, we present a proof-of-concept using read cloud sequencing to describe bacterial strain diversity in the gut microbiome of one hematopoietic cell transplantation patient over a 2-month time course and highlight temporal strain variation of gut microbes during therapy. The treatment was accompanied by diet changes and administration of multiple immunosuppressants and antimicrobials. We conducted short-read and read cloud metagenomic sequencing of DNA extracted from four longitudinal stool samples collected during the course of treatment of one hematopoietic cell transplantation (HCT) patient. After applying read cloud metagenomic assembly to discover strain-level sequence variants in these complex microbiome samples, we performed metatranscriptomic analysis to investigate differential expression of antibiotic resistance genes. Finally, we validated predictions from the genomic and metatranscriptomic findings through in vitro antibiotic susceptibility testing and whole genome sequencing of isolates derived from the patient stool samples. During the 56-day longitudinal time course that was studied, the patient's microbiome was profoundly disrupted and eventually dominated by Bacteroides caccae. Comparative analysis of B. caccae genomes obtained using read cloud sequencing together with metagenomic RNA sequencing allowed us to identify differences in substrain populations over time. Based on this, we predicted that particular mobile element integrations likely resulted in increased antibiotic resistance, which we further supported using in vitro antibiotic susceptibility testing. We find read cloud assembly to be useful in identifying key structural genomic strain variants within a metagenomic sample. These strains have fluctuating relative abundance over relatively short time periods in human microbiomes. We also find specific structural genomic variations that are associated with increased antibiotic resistance over the course of clinical treatment.
Sections du résumé
BACKGROUND
Populations of closely related microbial strains can be simultaneously present in bacterial communities such as the human gut microbiome. We recently developed a de novo genome assembly approach that uses read cloud sequencing to provide more complete microbial genome drafts, enabling precise differentiation and tracking of strain-level dynamics across metagenomic samples. In this case study, we present a proof-of-concept using read cloud sequencing to describe bacterial strain diversity in the gut microbiome of one hematopoietic cell transplantation patient over a 2-month time course and highlight temporal strain variation of gut microbes during therapy. The treatment was accompanied by diet changes and administration of multiple immunosuppressants and antimicrobials.
METHODS
We conducted short-read and read cloud metagenomic sequencing of DNA extracted from four longitudinal stool samples collected during the course of treatment of one hematopoietic cell transplantation (HCT) patient. After applying read cloud metagenomic assembly to discover strain-level sequence variants in these complex microbiome samples, we performed metatranscriptomic analysis to investigate differential expression of antibiotic resistance genes. Finally, we validated predictions from the genomic and metatranscriptomic findings through in vitro antibiotic susceptibility testing and whole genome sequencing of isolates derived from the patient stool samples.
RESULTS
During the 56-day longitudinal time course that was studied, the patient's microbiome was profoundly disrupted and eventually dominated by Bacteroides caccae. Comparative analysis of B. caccae genomes obtained using read cloud sequencing together with metagenomic RNA sequencing allowed us to identify differences in substrain populations over time. Based on this, we predicted that particular mobile element integrations likely resulted in increased antibiotic resistance, which we further supported using in vitro antibiotic susceptibility testing.
CONCLUSIONS
We find read cloud assembly to be useful in identifying key structural genomic strain variants within a metagenomic sample. These strains have fluctuating relative abundance over relatively short time periods in human microbiomes. We also find specific structural genomic variations that are associated with increased antibiotic resistance over the course of clinical treatment.
Identifiants
pubmed: 32471482
doi: 10.1186/s13073-020-00747-0
pii: 10.1186/s13073-020-00747-0
pmc: PMC7260799
doi:
Substances chimiques
Anti-Infective Agents
0
DNA, Bacterial
0
Immunosuppressive Agents
0
Ciprofloxacin
5E8K9I0O4U
Azithromycin
83905-01-5
Azacitidine
M801H13NRU
Types de publication
Case Reports
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
50Subventions
Organisme : NHGRI NIH HHS
ID : R01 HG006137
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007753
Pays : United States
Organisme : NHGRI NIH HHS
ID : P01 HG000205
Pays : United States
Organisme : NHGRI NIH HHS
ID : T32 HG000044
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA124435
Pays : United States
Organisme : NCI NIH HHS
ID : K08 CA184420
Pays : United States
Références
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Cold Spring Harb Symp Quant Biol. 1981;45 Pt 1:153-6
pubmed: 6271458
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4554-61
pubmed: 20847294
Mol Microbiol. 1993 Nov;10(3):465-71
pubmed: 7968525
Nature. 2013 Jul 25;499(7459):431-7
pubmed: 23851394
Antimicrob Agents Chemother. 1984 Mar;25(3):319-26
pubmed: 6232895
Bioinformatics. 2011 Mar 15;27(6):764-70
pubmed: 21217122
J Microbiol Methods. 2010 May;81(2):127-34
pubmed: 20171997
Nat Rev Genet. 2015 Aug;16(8):472-82
pubmed: 26184597
Int J Med Microbiol. 2011 Mar;301(3):229-36
pubmed: 21115395
Genome Res. 2016 Nov;26(11):1612-1625
pubmed: 27803195
Antimicrob Agents Chemother. 1994 Jan;38(1):104-14
pubmed: 8141562
J Appl Microbiol. 2000 May;88(5):784-90
pubmed: 10792538
Genome Biol. 2004;5(2):R12
pubmed: 14759262
Blood. 2014 Aug 14;124(7):1174-82
pubmed: 24939656
Antimicrob Agents Chemother. 1974 Feb;5(2):169-78
pubmed: 4275615
Nat Methods. 2014 Nov;11(11):1144-6
pubmed: 25218180
J Biol Chem. 2003 May 16;278(20):17852-8
pubmed: 12637552
Science. 2014 Apr 25;344(6182):416-20
pubmed: 24763590
Nat Biotechnol. 2017 Nov;35(11):1069-1076
pubmed: 28967887
Nat Biotechnol. 2015 Oct;33(10):1045-52
pubmed: 26344404
Nature. 2016 Jul 21;535(7612):435-439
pubmed: 27409808
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
Nat Biotechnol. 2015 Oct;33(10):1053-60
pubmed: 26368049
Eur J Biochem. 1987 Feb 2;162(3):473-6
pubmed: 3549289
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13950-5
pubmed: 16172379
Nat Biotechnol. 2018 Oct 15;:
pubmed: 30320765
Clin Infect Dis. 2012 Oct;55(7):905-14
pubmed: 22718773
Biol Blood Marrow Transplant. 2017 May;23(5):845-852
pubmed: 28232086
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
Curr Opin Microbiol. 2008 Oct;11(5):472-7
pubmed: 19086349
Genome Res. 2017 May;27(5):824-834
pubmed: 28298430
Nucleic Acids Res. 2013 Jan;41(Database issue):D36-42
pubmed: 23193287
Bioinformatics. 2012 Jun 1;28(11):1420-8
pubmed: 22495754
Antimicrob Agents Chemother. 2003 Mar;47(3):979-85
pubmed: 12604530
Nat Biotechnol. 2016 Mar;34(3):303-11
pubmed: 26829319
Genome Res. 2015 Oct;25(10):1570-80
pubmed: 26286554
Antimicrob Agents Chemother. 1978 Sep;14(3):384-90
pubmed: 708016
J Bacteriol. 2003 Feb;185(3):1101-6
pubmed: 12533487
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Curr Protoc Microbiol. 2008 May;Chapter 13:Unit 13C.1
pubmed: 18770533
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Microbiome. 2014 Aug 01;2:26
pubmed: 25136443
Nucleic Acids Res. 2012 Nov 1;40(20):e155
pubmed: 22821567
Nucleic Acids Res. 2004 Jan 02;32(1):11-6
pubmed: 14704338
Nucleic Acids Res. 2014 Jan;42(Database issue):D553-9
pubmed: 24316578
Cell. 2016 Nov 17;167(5):1339-1353.e21
pubmed: 27863247
Nat Biotechnol. 2020 Feb 10;:
pubmed: 32042169
Genome Res. 2017 Apr;27(4):626-638
pubmed: 28167665
Antimicrob Agents Chemother. 1998 Jul;42(7):1778-82
pubmed: 9661020
mBio. 2017 Feb 7;8(1):
pubmed: 28174306
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Cell Rep. 2016 Mar 29;14(12):2912-24
pubmed: 26997279
Antimicrob Agents Chemother. 2001 Apr;45(4):1238-43
pubmed: 11257040
Genome Res. 2015 Jul;25(7):1043-55
pubmed: 25977477
J Bacteriol. 2000 Oct;182(19):5365-72
pubmed: 10986238
Trends Genet. 2020 Jan;36(1):53-67
pubmed: 31780057
Nat Biotechnol. 2014 Aug;32(8):822-8
pubmed: 24997787
PeerJ. 2014 Sep 30;2:e603
pubmed: 25289188
Bioinformatics. 2016 Apr 1;32(7):1088-90
pubmed: 26614127
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Nat Biotechnol. 2017 Aug 8;35(8):725-731
pubmed: 28787424
PeerJ. 2015 Aug 27;3:e1165
pubmed: 26336640